The continuum of growth hormone-IGF-I axis defects causing short stature: Diagnostic and therapeutic challenges

Martin O. Savage, Christine P. Burren, Ronald (Ron) Rosenfeld

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

The growth hormone (GH)-IGF-I axis is essential for normal foetal and childhood growth. Defects at different sites in the axis frequently result in short stature which may compromise adult height. We describe a continuum of clinically relevant abnormalities from GH deficiency through to GH resistance and discuss the implementation and interpretation of investigations. We consider appropriate therapy for patients with abnormal auxology and subnormal adult height prognosis, highlighting new data to clarify therapeutic choices leading to optimal clinical outcome.

Original languageEnglish (US)
Pages (from-to)721-728
Number of pages8
JournalClinical Endocrinology
Volume72
Issue number6
DOIs
StatePublished - 2010

Fingerprint

Insulin-Like Growth Factor I
Growth Hormone
Fetal Development
Therapeutics

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Medicine(all)

Cite this

The continuum of growth hormone-IGF-I axis defects causing short stature : Diagnostic and therapeutic challenges. / Savage, Martin O.; Burren, Christine P.; Rosenfeld, Ronald (Ron).

In: Clinical Endocrinology, Vol. 72, No. 6, 2010, p. 721-728.

Research output: Contribution to journalArticle

Savage, Martin O. ; Burren, Christine P. ; Rosenfeld, Ronald (Ron). / The continuum of growth hormone-IGF-I axis defects causing short stature : Diagnostic and therapeutic challenges. In: Clinical Endocrinology. 2010 ; Vol. 72, No. 6. pp. 721-728.
@article{c5b615d4807a4acc9070f4c597a4d836,
title = "The continuum of growth hormone-IGF-I axis defects causing short stature: Diagnostic and therapeutic challenges",
abstract = "The growth hormone (GH)-IGF-I axis is essential for normal foetal and childhood growth. Defects at different sites in the axis frequently result in short stature which may compromise adult height. We describe a continuum of clinically relevant abnormalities from GH deficiency through to GH resistance and discuss the implementation and interpretation of investigations. We consider appropriate therapy for patients with abnormal auxology and subnormal adult height prognosis, highlighting new data to clarify therapeutic choices leading to optimal clinical outcome.",
author = "Savage, {Martin O.} and Burren, {Christine P.} and Rosenfeld, {Ronald (Ron)}",
year = "2010",
doi = "10.1111/j.1365-2265.2009.03775.x",
language = "English (US)",
volume = "72",
pages = "721--728",
journal = "Clinical Endocrinology",
issn = "0300-0664",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - The continuum of growth hormone-IGF-I axis defects causing short stature

T2 - Diagnostic and therapeutic challenges

AU - Savage, Martin O.

AU - Burren, Christine P.

AU - Rosenfeld, Ronald (Ron)

PY - 2010

Y1 - 2010

N2 - The growth hormone (GH)-IGF-I axis is essential for normal foetal and childhood growth. Defects at different sites in the axis frequently result in short stature which may compromise adult height. We describe a continuum of clinically relevant abnormalities from GH deficiency through to GH resistance and discuss the implementation and interpretation of investigations. We consider appropriate therapy for patients with abnormal auxology and subnormal adult height prognosis, highlighting new data to clarify therapeutic choices leading to optimal clinical outcome.

AB - The growth hormone (GH)-IGF-I axis is essential for normal foetal and childhood growth. Defects at different sites in the axis frequently result in short stature which may compromise adult height. We describe a continuum of clinically relevant abnormalities from GH deficiency through to GH resistance and discuss the implementation and interpretation of investigations. We consider appropriate therapy for patients with abnormal auxology and subnormal adult height prognosis, highlighting new data to clarify therapeutic choices leading to optimal clinical outcome.

UR - http://www.scopus.com/inward/record.url?scp=77952661532&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952661532&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2265.2009.03775.x

DO - 10.1111/j.1365-2265.2009.03775.x

M3 - Article

C2 - 20050859

AN - SCOPUS:77952661532

VL - 72

SP - 721

EP - 728

JO - Clinical Endocrinology

JF - Clinical Endocrinology

SN - 0300-0664

IS - 6

ER -